Todos os posts

Trajetórias de risco neurológico e psiquiátrico após infecção por SARS-CoV-2: análise de estudos de coorte retrospectiva de 2 anos incluindo 1.284.437 pacientes.

22 Ago, 2022 | 16:35h

Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients – The Lancet Psychiatry

Comunicado de imprensa: Increased risk of some neurological and psychiatric disorders remains two years after COVID-19 infection – University of Oxford

Comentário: Covid-19: Increased risk of some neurological and psychiatric disorders remains two years after infection, study finds – The BMJ

 

Comentário no Twitter

NEW—People with #COVID19 continue to face increased risks of some neurological and psychiatric conditions up to 2 years after infection, according to a study published in @TheLancetPsych: https://t.co/9fD5zMU3hE pic.twitter.com/8YhTKJ9v72

— The Lancet (@TheLancet) August 17, 2022

 

---

Análise agrupada de doença pulmonar intersticial relacionada a medicamentos e/ou pneumonite em 9 estudos de monoterapia com trastuzumabe deruxtecano.

22 Ago, 2022 | 16:34h

Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies – ESMO Open

Comentários:

Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced cancer – The Mount Sinai Health System

Trastuzumab deruxtecan-related ILD/pneumonitis characterized – medwire News

Conteúdo relacionado: Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review – Drugs

 

---

M-A | Intervenções para prevenção ou tratamento de febre materna associada a anestesia epidural.

22 Ago, 2022 | 16:32h

Interventions for the prevention or treatment of epidural-related maternal fever: a systematic review and meta-analysis – British Journal of Anaesthesia

 

---

Estudo randomizado | Efetividade de um programa de treinamento de exercícios domiciliar de longo prazo em pacientes com DPOC após reabilitação pulmonar.

22 Ago, 2022 | 16:31h

Effectiveness of a long-term home-based exercise training program in patients with COPD following pulmonary rehabilitation: A multi-center randomized controlled trial – CHEST

 

Comentário no Twitter

Effectiveness of a long-term home-based exercise training program in patients with COPD following pulmonary rehabilitation: A multi-center randomized controlled trialhttps://t.co/8u1nizaDNq pic.twitter.com/QwqzN1dDHK

— Physio Meets Science (@PhysioMeScience) August 17, 2022

Sob licença de Creative Commons

---

Estudo de modelagem | Redução da ingestão diária de sal em 1 g na China pode prevenir quase 9 milhões de eventos cardiovasculares até 2030.

22 Ago, 2022 | 16:29h

Reducing daily salt intake in China by 1 g could prevent almost 9 million cardiovascular events by 2030: a modelling study – BMJ Nutrition Prevention & Health

Comunicado de imprensa: 1 g cut in daily salt intake could ward off nearly 9 million cases of stroke/heart disease in China – BMJ Newsroom

 

---

Estudo de braço único fase 2 | Segurança e eficácia do mitapivate, ativador oral da piruvatequinase, em adultos com alfatalassemia ou betatalassemia não dependente de transfusão.

22 Ago, 2022 | 16:28h

Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study – The Lancet (link para o resumo – $ para o texto completo)

Comentário: PK Modulator Shows Promise in Thalassemia — In small study, mitapivat increased hemoglobin in 80% of non-transfusion-dependent patients – MedPage Today (necessário cadastro gratuito)

 

---

Estudo randomizado | Ceftolozano/tazobactam com metronidazol vs. meropeném em pacientes com infecções intra-abdominais complicadas.

22 Ago, 2022 | 16:26h

A Phase 3, Multicenter, Double-blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem in Chinese Participants With Complicated Intra-abdominal Infections – International Journal of Infectious Diseases

 

---

Prevenção de natimortos: uma revisão de rastreamento e estratégias de prevenção.

22 Ago, 2022 | 16:25h

Preventing Stillbirth: A Review of Screening and Prevention Strategies – Maternal-Fetal Medicine

 

---

Revisão | Síndrome autoimune/autoinflamatória induzida por adjuvantes: foco no silicone.

22 Ago, 2022 | 16:24h

Autoimmune/autoinflammatory syndrome induced by adjuvants: a focus on silicone – Clinical Rheumatology

 

Comentário no Twitter

🔥Check out a NEW review on #autoimmune/autoinflammatory syndrome induced by #adjuvants (ASIA): a focus on #silicone
👉https://t.co/ctLoUi79KN pic.twitter.com/BZCpp7iM8t

— ClinRheumatol (@ClinRheumatol) August 17, 2022

 

---

Tendências do tratamento ativo de neonatos nascidos vivos entre 22 semanas/0 dias e 25 semanas/6 dias de acordo com a idade gestacional e a etnia materna nos EUA, 2014 a 2020.

22 Ago, 2022 | 16:23h

Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020 – JAMA (link para o resumo – $ para o texto completo)

Comentários:

Study finds racial, ethnic disparities in rate of medical intervention among earliest premature babies – The Ohio State University

Active Treatment for Extremely Preterm Babies on the Rise — Yet researchers find racial and ethnic disparities in treatment initiation – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter

From 2014 to 2020 in the US, the frequency of active treatment among neonates born alive between 22 weeks 0 days and 25 weeks 6 days significantly increased, and there were differences in rates of active treatment by race and ethnicity. https://t.co/Xflqhxklul #Research

— JAMA (@JAMA_current) August 17, 2022

 

---